Human Health Division (HHD) Products

Product List by Therapeutic
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Chloramphenicol + Dexamethasone

Composition
Stedex -C  Sterile  Eye/Ear  Drops:  Each  ml  drops  contains 
Chloramphenicol BP 5 mg & Dexamethasone Phosphate USP 1 mg..

Indications
Eye: For steroid-responsive inflammatory ocular condition for which a corticosteriod is indicated and where bacterial infection or a risk of bacterial  ocular  infection  exists.  For  inflammatory  conditions  of  the palpebral and bulbar conjunctiva, cornea and anterior segment of the
globe  where  the  inherent  risk  of  steroid  use  in  certain  infective conjunctivitis  is  accepted  to  obtain  a  diminution  in  edema  and inflammation.  For  chronic  anterior  uveitis  and  corneal  injury  from chemical, radiation or thermal burns, or penetration of foreign bodies.
Ear: Otitis externa, Otitis media and chronic suppurative otitis media.

Dosage & Administration
Eye: 1 or 2 drops is instilled into the affected eyes every 3 or 4 hours, or more  frequently  if  deemed  advisable  by  the  prescribing  physician.
Administration should be continued day and night for the first 48 hours, after  which  the  interval  between  applications  may  be  increased. Treatment should be continued for at least 48 hours after the eye appears normal or as directed by the physician. 

Ear: For all infections two to three drops every two to three hours initially. Frequency should be decreased gradually as warranted by improvement in  clinical  signs.  Care  should  be  taken  not  to  discontinue  therapy prematurely or as directed by the physician.

Loteprednol Etabonate + Tobramycin

Composition
Loteba™ Sterile Eye Suspension: Each ml contains Loteprednol
Etabonate INN 5 mg and Tobramycin USP 3 mg.

Indications
Loteba™ is indicated for steroid responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. The use of a combination drug with an anti-infective component is indicated
where the risk of superficial ocular infection is high, where dangerous number of bacteria will be present in the eye.

Dosage and administration 
Shake the bottle well before use Apply 1 to 2 drops of Loteba™ into the conjunctival sac of the affected eye (s) every 4 to 6 hours. During the initial 24 to 48 hours, the dosing may be increased, to every 1 to 2 hours. Frequency should be
decreased gradually as warranted by improvement in clinical signs. Care should be taken not to discontinue therapy prematurely or as directed by the physician


Moxifloxacin + Dexamethasone

Composition:
Cinagen™-D Sterile Eye Drops: Each ml contains Moxifloxacin
Hydrochloride BP equivalent to Moxifloxacin 5 mg and Dexamethasone Sodium Phosphate USP equivalent to Dexamethasone Phosphate 1 mg.
Preservative: Sodium Perborate BP 0.001%.

Indications:
Cinagen™-D Sterile Eye Drops is indicated for the treatment of eye infections caused by susceptible microorganisms and prevention of inflammation and bacterial infection occurred after ocular surgery.

Dosage and administration:
In the prevention of infection and postoperative ocular inflammation, instill 1 drop 4 times per day. Frequency should be decreased gradually with improvement of clinical signs or as directed by the physician.